TY  - JOUR
AU  - Sanmartin Fernandez, Marcelo
AU  - Anguita Sanchez, Manuel
AU  - Arribas, Fernando
AU  - Baron-Esquivias, Gonzalo
AU  - Barrios, Vivencio
AU  - Cosin-Sales, Juan
AU  - Esteve-Pastor, Maria Asuncion
AU  - Freixa-Pamias, Roman
AU  - Lekuona, Iñaki
AU  - Perez-Cabeza, Alejandro I
AU  - Ureña, Isabel
AU  - Vazquez Rodriguez, Jose Manuel
AU  - Rafols Priu, Carles
AU  - Marin, Francisco
PY  - 2022
DO  - 10.5603/CJ.a2022.0044
UR  - http://hdl.handle.net/10668/21661
T2  - Cardiology journal
AB  - The aim of the study was to evaluate the performance of the 2MACE in patients with atrial fibrillation (AF) treated with rivaroxaban and to improve the accuracy of 2MACE. This was a post-authorization and observational study of AF adults treated with...
LA  - en
KW  - Atrial fibrillation
KW  - Bleeding
KW  - Major adverse cardiac events (MACE)
KW  - Rivaroxaban
KW  - Atroke
KW  - Adult
KW  - Anticoagulants
KW  - Atrial Fibrillation
KW  - Follow-Up Studies
KW  - Hemorrhage
KW  - Humans
KW  - Prospective Studies
KW  - Risk Factors
KW  - Rivaroxaban
KW  - Stroke
TI  - Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study.
TY  - research article
VL  - 29
ER  -